Ftse Mib
36.147,06
-0,12%
DAX
21.430,58
0,71%
S&P 500
6.067,70
0,92%
NASDAQ
19.733,59
2,03%
Bitcoin
102.210,54
0,87%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ HilleVax Inc (HLVX) HilleVax Inc (HLVX) Notizie

HLVX

HilleVax (HLVX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:HLVX
DataOraFonteTitoloSimboloCompagnia
05/12/202422:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HLVXHilleVax Inc
07/11/202414:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HLVXHilleVax Inc
07/11/202414:00GlobeNewswire Inc.HilleVax Reports Third Quarter 2024 Financial Results and Highlights Recent Company ProgressNASDAQ:HLVXHilleVax Inc
09/08/202401:20GlobeNewswire Inc.HilleVax Reports Second Quarter 2024 Financial Results and Highlights Recent Company ProgressNASDAQ:HLVXHilleVax Inc
31/07/202422:00GlobeNewswire Inc.HilleVax Announces Reduction in ForceNASDAQ:HLVXHilleVax Inc
09/07/202412:54IH Market NewsBP Slashes Profit Forecast by $700 Million; Morgan Stanley Predicts S&P 500 10% Drop, and More NewsNASDAQ:HLVXHilleVax Inc
08/07/202413:30GlobeNewswire Inc.HilleVax Reports Topline Data from NEST-IN1 Phase 2b Clinical Study of HIL-214 in InfantsNASDAQ:HLVXHilleVax Inc
10/05/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:HLVXHilleVax Inc
09/05/202422:05GlobeNewswire Inc.HilleVax Reports First Quarter 2024 Financial Results and Highlights Recent Company ProgressNASDAQ:HLVXHilleVax Inc
20/03/202421:00GlobeNewswire Inc.HilleVax Reports Full Year 2023 Financial Results and Highlights Recent Company ProgressNASDAQ:HLVXHilleVax Inc
13/02/202401:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HLVXHilleVax Inc
05/02/202422:05GlobeNewswire Inc.HilleVax to Present at Guggenheim 6th Annual Biotechnology ConferenceNASDAQ:HLVXHilleVax Inc
26/01/202423:00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:HLVXHilleVax Inc
18/01/202413:49Dow Jones NewsHilleVax Taps Sean McLoughlin as Chief Operating OfficerNASDAQ:HLVXHilleVax Inc
18/01/202413:00GlobeNewswire Inc.HilleVax Announces Executive Management Appointment of Sean McLoughlin as Chief Operating OfficerNASDAQ:HLVXHilleVax Inc
08/01/202413:00GlobeNewswire Inc.HilleVax and Kangh Announce Exclusive License Agreement for Hexavalent VLP Norovirus Vaccine Candidate Outside of ChinaNASDAQ:HLVXHilleVax Inc
04/01/202400:28GlobeNewswire Inc.HilleVax to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:HLVXHilleVax Inc
18/12/202323:28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:HLVXHilleVax Inc
09/11/202322:05GlobeNewswire Inc.HilleVax Reports Third Quarter 2023 Financial Results and Highlights Recent Company ProgressNASDAQ:HLVXHilleVax Inc
01/11/202321:48GlobeNewswire Inc.HilleVax to Present at Upcoming Investor ConferencesNASDAQ:HLVXHilleVax Inc
26/09/202322:01GlobeNewswire Inc.HilleVax to Participate in Fireside Chat at the 2023 Cantor Global Healthcare ConferenceNASDAQ:HLVXHilleVax Inc
25/09/202313:00GlobeNewswire Inc.HilleVax Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional SharesNASDAQ:HLVXHilleVax Inc
20/09/202322:01Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:HLVXHilleVax Inc
20/09/202302:05GlobeNewswire Inc.HilleVax Announces Pricing of Public Offering of Common StockNASDAQ:HLVXHilleVax Inc
19/09/202322:09GlobeNewswire Inc.HilleVax Announces Proposed Public Offering of Common StockNASDAQ:HLVXHilleVax Inc
14/08/202313:00GlobeNewswire Inc.HilleVax Reports Second Quarter 2023 Financial Results and Highlights Recent Company ProgressNASDAQ:HLVXHilleVax Inc
22/06/202322:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HLVXHilleVax Inc
21/06/202300:07Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:HLVXHilleVax Inc
10/06/202300:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HLVXHilleVax Inc
12/05/202322:56Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:HLVXHilleVax Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:HLVX

La tua Cronologia

BIT
UCG
Unicredit
BIT
STLAM
Stellantis NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ISP
Intesa Sanpaolo
BIT
TIT
Telecom Italia
BIT
ENEL
Enel
BIT
STMMI
ST Microelectronics
BIT
MB
Mediobanca Banca di Cred...
BIT
PRY
Prysmian
BIT
ENI
Eni
BIT
RACE
Ferrari NV
BIT
SPM
Saipem
BIT
BAMI
Banco BPM
BIT
BPE
Bper Banca
BIT
CPR
Davide Campari
BIT
G
Generali
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network